PFG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Principal Financial Group Inc (PFG) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong EPS growth and positive earnings in Q1 2026, the lack of significant bullish trading signals, neutral insider and hedge fund activity, and mixed analyst ratings suggest a cautious approach. Additionally, the stock is trading near resistance levels, which may limit immediate upside potential.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), and the MACD histogram is positive at 0.564, indicating upward momentum. However, the RSI of 71.701 is approaching overbought territory, suggesting limited room for further immediate gains. The stock is trading near its resistance level of 97.694, with a pre-market price of 96.74.
Q1 non-GAAP EPS of $2.17 exceeded expectations by $0.
The company aims for 9%-12% EPS growth in 2026 with planned capital deployments of $1.5 billion to $1.8 billion.
Acquisition of a dental benefits network in Alabama to expand market share.
Margin expansion and portfolio optimization highlighted at the Bank of America Financial Services Conference.
Revenue dropped to $0 in Q1 2026, down -100% YoY.
Analysts maintain mixed ratings, with some expressing concerns over organic growth and economic uncertainty.
Trading trends from hedge funds and insiders are neutral, indicating no significant bullish sentiment.
In Q1 2026, the company reported a significant increase in net income (up 782.74% YoY) and EPS (up 819.05% YoY). However, revenue dropped to $0, down -100% YoY, which raises concerns about the sustainability of growth.
Analyst ratings are mixed. Barclays maintains an Underweight rating with a price target of $87, citing weaker market performance and sluggish premium growth. UBS and BofA have Neutral ratings with price targets of $94 and $92, respectively. Morgan Stanley has an Equal Weight rating with a $95 price target, while Wells Fargo upgraded the stock to Equal Weight with a $91 price target, citing less downside risk.
